论文部分内容阅读
目的探索药物离子导入治疗对结核性包裹性胸腔积液患者治疗效果及积液吸收时间的影响。方法选择结核性包裹性胸腔积液患者78例,随机分为治疗组40例和对照组38例,对照组仅接受常规治疗,治疗组在常规治疗的基础上应用药物离子导入治疗。2组患者均于治疗后2个疗程观察治疗效果及积液吸收时间。结果治疗组和对照组总有效率分别是92.5%%和76.3%,胸水吸收时间分别是(18.0±6.1)d和(22.0±5.7)d;治疗组与对照组相比差异均有统计学意义(P<0.05)。结论药物离子导入治疗可以明显提高结核性包裹性胸腔积液患者的临床治疗效果,缩短胸水吸收时间。
Objective To explore the effect of drug iontophoresis on the therapeutic effect and effusion absorption time of patients with tuberculous pleural effusion. Methods Seventy-eight patients with tuberculous pleural effusion were randomly divided into treatment group (40 cases) and control group (38 cases). The control group received routine treatment only. The treatment group was treated with drug iontophoresis on the basis of routine treatment. Two groups of patients were observed after treatment for 2 courses of treatment and effusion absorption time. Results The total effective rates of the treatment group and the control group were 92.5 %% and 76.3%, respectively, and the pleural effusion time was (18.0 ± 6.1) days and (22.0 ± 5.7) days respectively. There was significant difference between the treatment group and the control group (P <0.05). Conclusion Drug iontophoresis can significantly improve the clinical efficacy of tuberculous pleural effusion and shorten the time of pleural effusion.